14/08/2026
CarbConnect® is heading to India.
CarbGeM Inc. has been selected for METI's FY2026 Healthcare Industry International Expansion Promotion Program Grant (managed by Medical Excellence JAPAN) for a demonstration study on introducing DX/AI solutions in the field of bacterial infections in the Republic of India.
In India, antimicrobial resistance (AMR) is reported to be among the leading causes of death, ahead of HIV/AIDS and malaria. In rural areas and smaller facilities, laboratory equipment and specialists are in short supply, so samples are shipped to central labs in cities — and results can take several days.
Building on last year's feasibility study, this project will assess the local deployment potential and market fit of CarbConnect®, our cloud-based AI image analysis and data collaboration platform, and test a sustainable business model for implementation in the Indian market.
Read more (Japanese): https://buff.ly/ch4iFzF